Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Vertical Research Upgrades Canadian National Railway to Buy

Vertical Research analyst Jeffrey Kauffman upgrades Canadian National Railway (NYSE:CNI) from Hold to Buy.

byBenzinga Newsdesk

May 18, 2021

1 minute read

Vertical Research analyst Jeffrey Kauffman upgrades Canadian National Railway (NYSE:CNI) from Hold to Buy.

Analyst Ratings

What 8 Analyst Ratings Have To Say About EnLink Midstream

By Benzinga Insights

Today, 1:44 PM

EnLink Midstream (NYSE:ENLC) has observed the following analyst ratings within the last quarter:

ENLC

Prelude Therapeutics Q3 EPS $(0.66) Up From $(5.25) YoY

By Benzinga Newsdesk

Today, 1:44 PM

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.66) per share. This is a 87.43 percent increase over losses of $(5.25) per share from the same period last year.

PRLD

Truist Securities Maintains Buy on Tempur Sealy Intl, Lowers Price Target to $37

By Benzinga Newsdesk

Today, 1:44 PM

Truist Securities analyst Keith Hughes maintains Tempur Sealy Intl (NYSE:TPX) with a Buy and lowers the price target from $45 to $37.

TPX

Analysts Bump Up SAIC Price Target Post Q1 Results

By Akanksha Bakshi

Today, 1:44 PM

Science Applications International Corp (NYSE:SAIC) price target was raised by Cowen and Barclays post its Q1 results. Cowen analyst Cai von Rumohr raised the price…

SAIC

Vertical Research Upgrades Canadian National Railway to Buy

Related Posts

What 8 Analyst Ratings Have To Say About EnLink Midstream

Prelude Therapeutics Q3 EPS $(0.66) Up From $(5.25) YoY

Truist Securities Maintains Buy on Tempur Sealy Intl, Lowers Price Target to $37

Analysts Bump Up SAIC Price Target Post Q1 Results